Genomtec

Genomtec Shares Outstanding

The The number of shares of Genomtec (GMT.WA) as of Nov 11, 2026 is 15.06 M. In the previous year, The number of shares was 15.06 M — a change of 0.00% (lower).

Shares Outstanding

15.06 M

YoY

0.00%

Last updated:

In 2025, Genomtec had 15.06 M outstanding stocks, a 0.00% change from the 15.06 M stocks in the previous year.

The Genomtec Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2018
15.06 M PLN
Jan 1, 2019
15.06 M PLN
Jan 1, 2020
15.06 M PLN
Jan 1, 2021
15.06 M PLN
Jan 1, 2022
15.06 M PLN
Jan 1, 2023
15.06 M PLN
Jan 1, 2024
15.06 M PLN
Jan 1, 2025
15.06 M PLN
The Genomtec Shares Outstanding history
YEARShares OutstandingYoY
15.06 M0.00%
15.06 M0.00%
15.06 M0.00%
15.06 M0.00%
15.06 M0.00%
15.06 M0.00%
15.06 M0.00%
15.06 M—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genomtec Number of shares

Genomtec shares outstanding

The number of shares of Genomtec was 15.06 M in 2025. This indicates how many shares Genomtec is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
17.06 M Stocks
Jan 1, 2019
8.16 M Stocks
Jan 1, 2020
8.16 M Stocks
Jan 1, 2021
8.16 M Stocks
Jan 1, 2022
9.36 M Stocks
Jan 1, 2023
12.26 M Stocks
Jan 1, 2024
13.32 M Stocks
Jan 1, 2025
15.06 M Stocks

Genomtec Stock analysis

What does Genomtec do? Genomtec SA generates revenue by researching and developing molecular diagnostic equipment, specifically focusing on the Genomtec ID mobile platform. This technology enables genetic diagnosis at the point of patient care, eliminating the need for complex laboratory workflows and qualified personnel. The platform is designed for use in primary care clinics, pharmacies, doctor’s offices, and hospital emergency departments. Genomtec is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating Genomtec's Shares Outstanding

Genomtec's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Genomtec’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Genomtec’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Genomtec’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Genomtec stock

The number of shares of Genomtec is 15.06 M in 2025.

The number of shares of Genomtec changed from 15.06 M to 15.06 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares Genomtec since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Other — Genomtec

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — Genomtec